Tower Research Capital (TRC)’s Virpax Pharmaceuticals, Inc. Common Stock VRPX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-4,897
| Closed | -$5.88K | – | 5698 |
|
|
2025
Q1 | $5.88K | Buy |
4,897
+4,587
| +1,480% | +$5.5K | ﹤0.01% | 4081 |
|
|
2024
Q4 | $2.95K | Buy |
310
+157
| +103% | +$1.49K | ﹤0.01% | 4742 |
|
|
2024
Q3 | $2.66K | Buy |
153
+27
| +21% | +$470 | ﹤0.01% | 4953 |
|
|
2024
Q2 | $1.63K | Buy |
126
+68
| +117% | +$878 | ﹤0.01% | 5123 |
|
|
2024
Q1 | $6.17K | Buy |
58
+33
| +132% | +$3.51K | ﹤0.01% | 4420 |
|
|
2023
Q4 | $2.02K | Hold |
25
| – | – | ﹤0.01% | 5287 |
|
|
2023
Q3 | $4.98K | Buy |
25
+3
| +14% | +$597 | ﹤0.01% | 4781 |
|
|
2023
Q2 | $5.87K | Hold |
22
| – | – | ﹤0.01% | 4757 |
|
|
2023
Q1 | $4K | Buy |
22
+1
| +5% | +$182 | ﹤0.01% | 5139 |
|
|
2022
Q4 | $3K | Buy |
21
+3
| +17% | +$429 | ﹤0.01% | 5281 |
|
|
2022
Q3 | $5K | Buy |
18
+8
| +80% | +$2.22K | ﹤0.01% | 5192 |
|
|
2022
Q2 | $4K | Buy |
+10
| New | +$4K | ﹤0.01% | 5290 |
|
|
2022
Q1 | – | Sell |
-3
| Closed | -$2K | – | 6759 |
|
|
2021
Q4 | $2K | Buy |
+3
| New | +$2K | ﹤0.01% | 5707 |
|